YH-02

AXP000062.1 · Oncolytic virus

Platform
adenovirus
Sponsor
Tianjin First Central Hospital

Names

NameTypeSource
YH-02 ambiguouspreferred name, codecurator, ctgov

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus (serotype not reported)
Replication
conditionally replicating
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT07697937YH02 Injection for Intra-tumor Injection Therapy in Advanced Solid Tumors With Unresponsive or Failure-Treated CasesRecruitingPhase 22026-06-232028-05-3150Advanced Malignant Solid Tumor

Recent changes

No changes recorded in its trials yet.

Clinical papers

No confirmed clinical papers yet.

Other papers

Preclinical studies, reviews and other papers that name it.

No confirmed other papers yet.

Unconfirmed matches (2)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 40635172Chemical Constituents of Rabdosia Species and Their Antimicrobial and Antioxidant Activities in Extending Meat Shelf Life.Journal of food science2025name in abstract: YH-02
PMID 24812969[Risk assessment and countermeasures of heavy metals pollution in Wanquan segment of Yanghe River].Huan jing ke xue= Huanjing kexue2014name in abstract: YH-02

Notes

Oncolytic adenovirus in trial NCT07697937. Construct not described; classification as an adenovirus rests on the trial's indexing and should be re-checked.

How to cite

YH-02 (AXP000062.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000062.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.